BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9602704)

  • 1. Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa.
    Jasani B; Campbell F; Navabi H; Schmid KW; Williams GT
    J Pathol; 1998 Feb; 184(2):144-7. PubMed ID: 9602704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crypt-restricted metallothionein immunopositivity in murine colon: validation of a model for studies of somatic stem cell mutation.
    Anne Cook H; Williams D; Anne Thomas G
    J Pathol; 2000 Jul; 191(3):306-12. PubMed ID: 10878553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human colonic stem cell mutation frequency with and without irradiation.
    Campbell F; Fuller CE; Williams GT; Williams ED
    J Pathol; 1994 Nov; 174(3):175-82. PubMed ID: 7823250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of somatic mutation and colonic crypt clonality by X-linked enzyme histochemistry.
    Griffiths DF; Davies SJ; Williams D; Williams GT; Williams ED
    Nature; 1988 Jun; 333(6172):461-3. PubMed ID: 3374587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No difference in stem cell somatic mutation between the background mucosa of right- and left-sided sporadic colorectal carcinomas.
    Campbell F; Appleton MA; Shields CJ; Williams GT
    J Pathol; 1998 Sep; 186(1):31-5. PubMed ID: 9875137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crypt fission in the small intestine and colon. A mechanism for the emergence of G6PD locus-mutated crypts after treatment with mutagens.
    Park HS; Goodlad RA; Wright NA
    Am J Pathol; 1995 Nov; 147(5):1416-27. PubMed ID: 7485404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in susceptibility to colonic stem cell somatic mutation in three strains of mice.
    Kuraguchi M; Cook H; Williams ED; Thomas GA
    J Pathol; 2001 Apr; 193(4):517-21. PubMed ID: 11276012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional analysis of isolated hexosaminidase-altered aberrant crypts from colons of 1,2-dimethylhydrazine-treated rats.
    Tsukamoto T; Sakai H; Hirata A; Fukami H; Tatematsu M
    Exp Toxicol Pathol; 2006 Mar; 57(4):283-9. PubMed ID: 16414254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stem cell niche theory of intestinal crypt maintenance based on a study of somatic mutation in colonic mucosa.
    Williams ED; Lowes AP; Williams D; Williams GT
    Am J Pathol; 1992 Oct; 141(4):773-6. PubMed ID: 1415475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallothionein colon crypt immuno-positivity as a rapid in vivo essay for drug efficacy studies.
    Mori F; Della Rocca C; Lazzaro D
    In Vivo; 2012; 26(4):693-702. PubMed ID: 22773584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of N-methyl-N-nitrosourea-induced crypt restricted metallothionein immunopositivity in mouse colon by a non-genotoxic diet-related chemical.
    Donnelly ET; Bardwell H; Thomas GA; Williams ED; Hoper M; Crowe P; McCluggage WG; Stevenson M; Phillips DH; Hewer A; Osborne MR; Campbell FC
    Carcinogenesis; 2004 May; 25(5):847-55. PubMed ID: 14729593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallothionein null cells have increased sensitivity to anticancer drugs.
    Kondo Y; Woo ES; Michalska AE; Choo KH; Lazo JS
    Cancer Res; 1995 May; 55(10):2021-3. PubMed ID: 7743495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
    Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
    Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Necl-5 in the pathophysiology of colorectal lesions induced by dimethylhydrazine and/or dextran sodium sulphate.
    Abe A; Fukui H; Fujii S; Kono T; Mukawa K; Yoshitake N; Sekikawa A; Ichikawa K; Tomita S; Yamagishi H; Imai Y; Shinoda M; Ishizaki H; Tanaka-Okamoto M; Kubota K; Miyoshi J; Takai Y; Fujimori T
    J Pathol; 2009 Jan; 217(1):42-53. PubMed ID: 18973187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potent colon carcinogen, 1,2-dimethylhydrazine induces mutations primarily in the colon.
    Newell LE; Heddle JA
    Mutat Res; 2004 Nov; 564(1):1-7. PubMed ID: 15474405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein, an endogenous antioxidant, protects against retinal neuron damage in mice.
    Suemori S; Shimazawa M; Kawase K; Satoh M; Nagase H; Yamamoto T; Hara H
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3975-82. PubMed ID: 16936113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial variation in the O-acetylation phenotype of human colonic mucosa.
    Campbell F; Appleton MA; Fuller CE; Greeff MP; Hallgrimsson J; Katoh R; Ng OL; Satir A; Williams GT; Williams ED
    J Pathol; 1994 Nov; 174(3):169-74. PubMed ID: 7823249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.